Similar Articles
901 Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma
902 Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients
903 Importance of SALL4 in the development and prognosis of hepatocellular carcinoma
904 Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
905 Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
906 Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?
907 Hepatocellular carcinoma: Where are we?
908 Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan
909 Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?
910 Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA